Approval · Notice of Compliance 6085 · 2002
SYNOVEX C IMPLANTS: Notice of Compliance 6085
Issued June 21, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6085
- Date
- June 21, 2002
- Company
- Ayerst Veterinary LaboratoriesGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes in manufacturing
- Therapeutic class
- Growth promotant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNOVEX C IMPLANTS | 00618675 | Marketed |
Medicinal ingredients
- PROGESTERONE 100 MG per IMP
- ESTRADIOL BENZOATE 10 MG per IMP